Anixa Biosciences, Inc.
ANIX
$2.76
$0.031.10%
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.71% | 1.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.05% | -11.94% | |||
| Operating Income | -7.05% | 11.94% | |||
| Income Before Tax | -10.30% | 12.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.30% | 12.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -3.33% | -21.05% | |||
| Net Income | -10.44% | 12.02% | |||
| EBIT | -7.05% | 11.94% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -10.38% | 12.33% | |||
| Normalized Basic EPS | -10.61% | 12.44% | |||
| EPS Diluted | -10.38% | 12.33% | |||
| Normalized Diluted EPS | -10.61% | 12.44% | |||
| Average Basic Shares Outstanding | 0.05% | 0.39% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
